Ob/Gyn Updated
Your Web destination for the latest in Evidence based Obstetrics, Gynecology and Women’s health.
Showing posts with label
Eli Lilly’s
.
Show all posts
Showing posts with label
Eli Lilly’s
.
Show all posts
Thursday, March 1, 2018
Eli Lilly’s Verzenio cleared by FDA as first line therapy in advance metastatic breast cancer
›
U.S. Food and Drug Administration (FDA) today cleared Eli Lilly’s Verzenio TM (abemaciclib) for use as initial endocrine-based therapy...
3 comments:
›
Home
View web version
